Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
Prevalence Survey for Innovative and Intensified Disease Management (IDM) Neglected Tropical Diseases (NTDs): A Cluster Randomised Two-stage Active Case Search for IDM-NTDs in Liberia
1 other identifier
observational
56,285
1 country
1
Brief Summary
Appropriate targeting of interventions for neglected tropical diseases (NTDs) that require innovative and intensified disease management (IDM) requires accurate data on the distribution of these diseases within endemic countries. In most instances however, existing case register data generated through national health management information systems or during programmatic activities do not provide an accurate representation of the true burden of IDM NTDs. This study will pilot a cluster randomized screening and confirmation survey to estimate the burden of IDM NTDs characterised by skin conditions associated with long-term disfigurement and disability. These include: leprosy, Buruli ulcer, yaws and lymphoedema and hydrocele resulting from lymphatic filariasis. The survey is being conducted in one county in Liberia. The protocol involves community-level screening by community health volunteers trained to use photo-based visual aids to recognise changes in the skin that broadly indicates patent infection. All suspected cases will be verified in their homes by local and national experts trained in the diagnosis of skin-presenting NTDs. The survey will generate accurate district-level prevalence estimates of leprosy, yaws, Buruli ulcer and lymphatic filariasis-associated lymphoedema and hydrocele and quantify the total costs and cost per case detected. In addition, results from this protocol will be compared with routinely collected case register data, to better understand how health system records reflect the true disease situation on the ground and quantify unmet need.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2018
CompletedFirst Submitted
Initial submission to the registry
September 19, 2018
CompletedFirst Posted
Study publicly available on registry
September 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedJune 10, 2024
June 1, 2024
5 months
September 19, 2018
June 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Population prevalence of Lymphatic Filariasis
Clinical signs of lymphoedema and hydrocele associated with lymphatic filariasis
Over a four month period
Population prevalence of Yaws
Clinical signs and PCR-confirmed yaws
Over a four month period
Population prevalence of Buruli Ulcer
Clinical signs and PCR-confirmed Buruli ulcer
Over a four month period
Secondary Outcomes (3)
Population prevalence of leprosy
Over a four month period
Population prevalence of BU and yaws in children
Over a four month period
Population prevalence of category 3 Buruli Ulcer
Over a four month period
Study Arms (1)
Maryland
Maryland is a county in southeast Liberia. Survey clusters based on catchment populations served by community health volunteers (CHVs) around 24 district health facilities (primary sampling unit). Clusters will constitute \~600 people (\~100 households) with population-weighted cluster selection applied. In total, 80 clusters will be required. CHVs would conduct house-to-house visits to develop a full census and listing of all possible cases using broad case definitions. Full details of all potential cases will then be passed to an expert verification team based at the closest health facility. Suspected cases will arrive at the health facility over a 10-day verification period to receive a diagnosis using clinical examination and/or laboratory confirmation.
Eligibility Criteria
All individuals resident in the study clusters, which were selected with probability proportional to size.
You may qualify if:
- Adults over 18 must be willing and able to give informed consent for examination, and children over 13 years must be willing and able to give informed assent
- An adult (\>18 year of age) parent or guardian must be present at the time of the examination who can give informed consent for children \<18 years to be examined.
You may not qualify if:
- Individuals for whom no adult parent/guardian is available to provide consent and/or who are unwilling to provide assent/consent for themselves.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- London School of Hygiene and Tropical Medicinelead
- AIM Initiativecollaborator
- Ministry of Health, Liberiacollaborator
Study Sites (1)
Maryland County
Harper, Maryland County, Liberia
Biospecimen
Specimens will be obtained from all clinically suspected cases, for confirmatory diagnosis. These include: * skin swabs of suspected yaws lesions * nasal swabs of suspected leprosy cases * skin swabs of Buruli ulcer lesions Samples will be tested using molecular analysis including PCR and sequencing for detection of T. pallidum, M. Ulcerans, M. leprae and other pathogens which can cause similar manifestations. Samples are to be stored (in Liberia, and in London) at -20 degrees in appropriately secured laboratory freezers (CL2 and CL3) for future research projects. This is explained in the information sheet, with a statement included in the consent forms.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel L Pullan, PhD
London School of Hygiene and Tropical Medicine
- PRINCIPAL INVESTIGATOR
Karsor Kollie, MSc
Ministry of Health, Liberia
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 19, 2018
First Posted
September 25, 2018
Study Start
June 14, 2018
Primary Completion
October 30, 2018
Study Completion
December 30, 2018
Last Updated
June 10, 2024
Record last verified: 2024-06